BioMarin Pharmaceutical (BMRN) News Today $68.16 -1.50 (-2.15%) (As of 10/3/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period 3 Oversold Stocks with Big RSI Rebound Potential (BMRN)Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. The RSI indicator is a great way to find them.October 3 at 9:09 AM | marketbeat.comThe Manufacturers Life Insurance Company Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)The Manufacturers Life Insurance Company increased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 177.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 180,617 shares of the biotechnology company's stock afOctober 3 at 4:12 AM | marketbeat.comTeachers Retirement System of The State of Kentucky Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Teachers Retirement System of The State of Kentucky raised its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 17.4% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 194,207 shares ofOctober 2 at 6:01 AM | marketbeat.com11,991 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Purchased by MBB Public Markets I LLCMBB Public Markets I LLC purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 11,991 shares of the biotechnology company's stocOctober 1 at 4:47 AM | marketbeat.comAndreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical IncOctober 1 at 4:15 AM | finance.yahoo.comAndreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc HoldingOctober 1 at 4:15 AM | finance.yahoo.comNovo Holdings A S Purchases 40,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Novo Holdings A S raised its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 8.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 490,000 shares of the biotechnology cSeptember 30, 2024 | marketbeat.comSusquehanna Fundamental Investments LLC Invests $5.63 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Susquehanna Fundamental Investments LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 68,346 shares of theSeptember 29, 2024 | marketbeat.comLighthouse Investment Partners LLC Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Lighthouse Investment Partners LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 63,000 shares of the biotechnology company's stock, valued at approximately $5September 28, 2024 | marketbeat.comDeerfield Management Company L.P. Series C Buys New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Deerfield Management Company L.P. Series C bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 9,832 shares of the biotechnology compaSeptember 27, 2024 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 12-Month Low at $68.73September 26, 2024 | americanbankingnews.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by DeepCurrents Investment Group LLCDeepCurrents Investment Group LLC decreased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.3% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 117,182 shares of the biotechnology company's stock after selling 1September 26, 2024 | marketbeat.comTruist Financial Sticks to Their Buy Rating for BioMarin Pharmaceutical (BMRN)September 26, 2024 | markets.businessinsider.com3 Biotech Stocks Wall Street Predicts Will SkyrocketSeptember 25, 2024 | stocknews.comBioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains BullishSeptember 25, 2024 | finance.yahoo.comBiomarin Pharmaceutical Options Trading: A Deep Dive into Market SentimentSeptember 25, 2024 | benzinga.com71,600 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Troluce Capital Advisors LLCTroluce Capital Advisors LLC bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 71,600 shares of the biotechnology company's stoSeptember 25, 2024 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 12-Month Low at $68.73BioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 1-Year Low at $68.73September 24, 2024 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Releases FY 2024 Earnings GuidanceSeptember 24, 2024 | americanbankingnews.comBioMarin Pharmaceutical (NASDAQ:BMRN) Issues FY 2024 Earnings GuidanceSeptember 24, 2024 | americanbankingnews.comHsbc Holdings PLC Has $7.41 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Hsbc Holdings PLC lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 61.4% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 89,795 shares of the biotechnology company's stock after selling 142,903 shares during the pSeptember 24, 2024 | marketbeat.com2 Social Media Stocks With Strong Long-Term PotentialSeptember 23, 2024 | stocknews.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Avoro Capital Advisors LLCAvoro Capital Advisors LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,557,416 shares ofSeptember 23, 2024 | marketbeat.comAmeritas Investment Partners Inc. Invests $3.33 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Ameritas Investment Partners Inc. bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 40,387 shares of the biotechnology coSeptember 22, 2024 | marketbeat.comBioMarin (BMRN): Strong Results and ROCTAVIAN Progress Make It a Mid-Cap Growth GemSeptember 21, 2024 | msn.comFederated Hermes Inc. Invests $1.66 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Federated Hermes Inc. purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 20,167 shares of the biotechnology company's stocSeptember 21, 2024 | marketbeat.comAmalgamated Bank Buys 85,177 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Amalgamated Bank lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 792.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 95,922 shares of the biotechnology company's stock after acquiring an additionalSeptember 20, 2024 | marketbeat.comBarclays Remains a Buy on BioMarin Pharmaceutical (BMRN)September 19, 2024 | markets.businessinsider.comQ1 2025 Earnings Forecast for BioMarin Pharmaceutical Inc. Issued By Zacks Research (NASDAQ:BMRN)BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Equities researchers at Zacks Research increased their Q1 2025 earnings per share estimates for shares of BioMarin Pharmaceutical in a note issued to investors on Monday, September 16th. Zacks Research analyst S. Ganoria now expects thatSeptember 19, 2024 | marketbeat.comE Fund Management Co. Ltd. Has $1.11 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)E Fund Management Co. Ltd. increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 167.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,480 shares of the biotechnology companySeptember 19, 2024 | marketbeat.comBioMarin Pharmaceutical (BMRN) Gets a Buy from Evercore ISISeptember 19, 2024 | markets.businessinsider.comBioMarin Pharmaceutical (BMRN) Gets a Hold from ScotiabankSeptember 18, 2024 | markets.businessinsider.comBioMarin's CANOPY Trial Shows Positive Data About Voxzogo In Children With AchondroplasiaSeptember 18, 2024 | markets.businessinsider.comBioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society MeetingSeptember 18, 2024 | prnewswire.comTexas Permanent School Fund Corp Invests $2.19 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Texas Permanent School Fund Corp acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 26,646 shares of thSeptember 18, 2024 | marketbeat.comBuy Rating on BioMarin: Competitive Edge and Undervalued Market PositionSeptember 17, 2024 | markets.businessinsider.comBioMarin Pharmaceutical (NASDAQ:BMRN) PT Lowered to $78.00Scotiabank reduced their price target on BioMarin Pharmaceutical from $95.00 to $78.00 and set a "sector perform" rating for the company in a research report on Tuesday.September 17, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Sees Significant Decrease in Short InterestBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 5,850,000 shares, a drop of 12.0% from the August 15th total of 6,650,000 shares. Based on an average daily trading volume, of 2,240,000 shares, the short-interest ratio is currently 2.6 days.September 17, 2024 | marketbeat.comPrimecap Management Co. CA Purchases 76,190 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Primecap Management Co. CA boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,790,085 shares of the biotechnology company's stock after buying an aSeptember 17, 2024 | marketbeat.comBioMarin Pharmaceutical Maintains Buy Rating Amid Competitor Challenges and Strong IP PositionSeptember 16, 2024 | markets.businessinsider.comDespite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near TermSeptember 16, 2024 | finance.yahoo.comBioMarin off 17% as Ascendis data seen as threat to VoxzogoSeptember 16, 2024 | msn.comBioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 1-Year Low at $72.90BioMarin Pharmaceutical (NASDAQ:BMRN) Sets New 52-Week Low at $72.90September 16, 2024 | marketbeat.comState of New Jersey Common Pension Fund D Sells 37,718 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)State of New Jersey Common Pension Fund D reduced its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 35.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 68,403 shares of the biotechnoSeptember 16, 2024 | marketbeat.comAGF Management Ltd. Purchases Shares of 31,130 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)AGF Management Ltd. purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 31,130 shares of the biotechnology company's stock, vaSeptember 14, 2024 | marketbeat.comHold Rating on BioMarin Maintained Amid Cautious Outlook on Voxzogo’s Revenue PotentialSeptember 14, 2024 | markets.businessinsider.com3 Healthcare Stocks With High Analyst Price TargetsSeptember 14, 2024 | stocknews.comBioMarin Pharmaceutical (NASDAQ:BMRN) Rating Reiterated by Canaccord Genuity GroupCanaccord Genuity Group reiterated a "hold" rating and set a $93.00 price target on shares of BioMarin Pharmaceutical in a research note on Friday.September 13, 2024 | marketbeat.comAndra AP fonden Buys Shares of 18,400 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Andra AP fonden purchased a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 18,400 shares of the biotechnology company's stock, valued aSeptember 13, 2024 | marketbeat.comRice Hall James & Associates LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Rice Hall James & Associates LLC trimmed its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 28.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,679 shares of the biotechnology company'September 12, 2024 | marketbeat.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼0.940.59▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼108▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SRPT News Today TEVA News Today VYGR News Today ALNY News Today BIIB News Today UTHR News Today INCY News Today EXAS News Today NBIX News Today RGEN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 10/4/2024 by MarketBeat.com Staff From Our PartnersThe world’s smartest man is in their crosshairsElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrade Alongside Pelosi, Buffett, and MorePeople don't know that you can trade alongside politicians, lawmakers, and top investors like Warren Buffet, B...Bullseye Trades | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredMassive NVIDIA Sell-Off: Are We Headed for a Market Collapse?You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this ye...Behind the Markets | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding BioMarin Pharmaceutical Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
